Two Sigma Advisers’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Two Sigma Advisers’s Portfolio SLGC Stock Details SLGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-33,400	Closed	-$84.5K	–	2710
2023 Q4	$84.5K	Buy	+33,400	New	+$77.8K	﹤0.01%	2344
2023 Q1	–	Sell	-128,300	Closed	-$322K	–	2797
2022 Q4	$322K	Buy	128,300 +41,600	+48%	+$116K	﹤0.01%	2042
2022 Q3	$251K	Buy	86,700 +70,200	+425%	+$296K	﹤0.01%	2130
2022 Q2	$75K	Buy	+16,500	New	+$98.2K	﹤0.01%	2426

Two Sigma Advisers's SLGC Position: Q1 2024 in Review

Two Sigma Advisers sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 33,400 shares — an estimated $84.5K sold.

Two Sigma Advisers first reported a position in SLGC in Q2 2022 and held it in 4 quarters. The position peaked at $322K in Q4 2022. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

Two Sigma Advisers reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Two Sigma Advisers sold 33,400 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $84.5K.
Two Sigma Advisers first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 4 quarters.
Two Sigma Advisers's SomaLogic, Inc. Class A Common Stock position peaked at $322K in Q4 2022.
0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.